Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
Replication failures limit clinical use of CVD genetic markers; leaves open whether rigorous designs with environmental data will improve replicability.
Visvikis‐Siest et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: